Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Mar 31;17(3):e0266094. doi: 10.1371/journal.pone.0266094

Profiling of phytochemicals from aerial parts of Terminalia neotaliala using LC-ESI-MS2 and determination of antioxidant and enzyme inhibition activities

Muhammad Nadeem Shahzad 1,*, Saeed Ahmad 1,*, Muhammad Imran Tousif 2, Imtiaz Ahmad 1,3, Huma Rao 1, Bilal Ahmad 1, Abdul Basit 1
Editor: A M Abd El-Aty4
PMCID: PMC8970405  PMID: 35358239

Abstract

Objectives

Owing to extraordinary healing power, Terminalia species have been used in traditional medicine systems to treat various diseases. Many folklore uses of Terminalia neotaliala (Madagascar’s almond) included treating arterial hypertension, diabetes, diarrhea, dysentery, colic, oral and digestive candidiasis, intestinal parasitic infections, inflammatory skin conditions, postpartum care, and mycotic infections but nevertheless scientifically explored for its medicinal and pharmacological importance. Therefore, the current study intended to prepare methanolic extract and its fractionation with hexane, chloroform, and butanol followed by evaluation of their polyphenolic content, biological activities, and LCMS analysis. The biological study included antioxidant activity and enzyme inhibition assay i.e., α-glucosidase and urease. The insight study of biologically active secondary metabolites of butanol fraction (BUAE) was performed through LCMS.

Methods

The total phenolic content (TPC) and total flavonoid content (TFC) of hydroalcoholic and its fractions were estimated using the Folin-Ciocalteu and aluminum chloride method. The total tannin content (TTC) was determined using the Folin-Denis spectrophotometric method. Similarly, the antioxidant potential of HAAE, HEAE, CFAE, and BUAE was determined using four methods as DPPH (1,1-diphenyl-2-picrylhydrazyl), 2,2-azinobis(3-ethylbenothiazoline)-6-sulfonic acid, cupric reducing antioxidant capacity (CUPRAC), and ferric reducing antioxidant power (FRAP). The sample extracts were also evaluated against two clinically important enzymes i.e., α-glucosidase and urease.

Results

The BUAE (butanol aerial fraction) showed the highest TPC (234.79 ± 0.12 mg.GAE.g-1 DE), TFC (320.75 ± 12.50 mg.QE.g-1 DE), and TTC (143.36 ± 4.32 mg.TA.Eq.g-1 DE). The BUAE also showed the highest scavenging potential determined by DPPH (642.65 ± 1.11 mg.TEq.g-1 DE) and ABTS (543.17 ± 1.11 mg.TEq.g-1 DE), and the metal-reducing capacity determined by CUPRAC (1510.41 ± 4.45 mg.TEq.g-1 DE) and FRAP (739.81 ± 19.32 mg.TEq.g-1 DE). The LCMS of BUAE identified 18 different biologically active phytoconstituents validating a rich source of hydrolyzable tannins including ellagitannins and gallitannins.

Conclusion

The present study concluded that T. neotaliala is a rich source of polyphenols capable of neutralizing the damage caused by free radical accumulation in the cells and tissues. The significant antioxidant results and identification of high molecular weight hydrolyzable tannins enlightened the medicinal importance of T. neotaliala.

1 Introduction

In consonance with a WHO report, approximately 80 percent of the world’s population relies on medicinal plants and herbal drugs [1]. The phytochemicals worked as defense soldiers to maintain human and animal health by regulating metabolic systems [2]. The ROS (reactive oxygen species) produced during metabolic processes negatively affected cellular components and disturbed their metabolic functions [3, 4]. The antioxidant prevented the accumulation of highly reactive oxygen species (ROS) and protected the cells against oxidative damage [5].

The production of scavengers, endogenous enzymes, and hormones [6] produced during the inflammatory disorders was found incapable to fight against excessive accumulation of highly ROS. The plants were reported rich sources of natural antioxidants which augmented the production of these endogenous molecules and protected the body from the negative effects of ROS [7].

Over the last three decades, more than 4000 antioxidants had been isolated from medicinal plants which include polyphenols such as flavonoids, proanthocyanidins, phenolic acids, tocopherols, tannins, coumarins, and anthraquinones [8, 9]. These phenolic compounds showed antioxidant activity owing to oxidation-reduction potential and metal-chelating effect [10].

Terminalia is the second-largest genus including 200 species [11]. The word “Terminalia” originated from the Latin word terminus (end or extremity of a thing, boundary, or limit) because the leaves grow at the tips of their shoots [12]. The Terminalia neotaliala (T. mantaly H. Perrier, T. obscordiformis) belongs to the family “Combretaceae” and is vernacularly known as Madagascar’s almond or the umbrella tree. It is a large endemic tree that grows to 20 m height in dry, humid, and subhumid forests at elevations of 0–500 m [10].

An extensive literature survey revealed its ethnobotanical use for treating arterial hypertension, gastroenteritis, diarrhea, dysentery, diabetes, colic, oral and digestive candidiasis, intestinal parasitic infections, inflammatory skin conditions, postpartum care, and mycotic infection. According to another study, leaf, and bark extracts of T. neotaliala were also used against hypertension, gastroenteritis, diabetes, skin conditions, oral and genital candidiasis [13].

The Terminalia species have been screened for their antioxidant potential by DPPH, superoxide radical scavenging, and FRAP assays and showed high antioxidant potential [11]. But the phytochemical and biological activity of T. neotaliala has not been detailed evaluated. In the present study, we prepared hydroalcoholic extract and its different solvent fractions followed by evaluation of their polyphenolic content, pharmacological activities such as antioxidant and enzyme inhibition. Qualitative metabolomic profiling of the butanol fraction of T. neotaliala was also performed using LCMS.

2 Materials and methods

2.1 Chemicals

Ascorbic acid, DPPH, quercetin, gallic acid, Folin–Ciocalteu reagent, ethanol, and methanol were procured from Merck (Darmstadt, Germany). Trolox (6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-carboxylic acid), aluminum chloride, sodium nitrite, sodium hydroxide, sodium dihydrogen phosphate, neocuproine, FeCl2, ABTS, ferrozine, EDTA, α-glucosidase, and urease were purchased from Sigma-Aldrich (St. Louis, MO, USA).

2.2 Plant material

The aerial parts of T. neotaliala were collected from different nurseries and gardens located in Bahawalpur, Punjab-Pakistan 63100, from September to October 2018. A taxonomist from the Herbarium Department of Botany-Faculty of Life Sciences, the Islamia University of Bahawalpur, identified the plant as Terminalia neotaliala and issued a voucher (59/botany dated the Bahawalpur 25th -Sep-2018).

2.3 Processing of plant material

The collected aerial parts were shade-dried and pulverized using a grinding mill. The powder was preserved in a hermetically sealed container and placed in a cool, dry, and dark area.

2.4 Preparation of plant extract

The 7 Kg dried powder was macerated in 80% hydroalcoholic solution for two weeks with occasional stirring. The supernatant was collected and filtered using Whatman filter paper no.1 followed by fine filtration through the Buchner funnel. The filtrate was concentrated and dried at 45°C using a rotary evaporator under reduced pressure. The extract was suspended in water and fractionated by liquid-liquid extraction using hexane, chloroform, and butanol in increasing order of their polarity. The HEAE (hexane aerial fraction 20 g), ‘CFAE’ (chloroform aerial fraction 120 g), and ‘BUAE’ (butanol aerial fraction 90 g) sample extracts were secured through fractionation of HAAE (hydroalcoholic aerial extract 255g).

2.5 Phytochemical screening

The phytochemical analysis of the methanolic extract and its fractions was performed to identify primary and secondary metabolites. The screening for primary metabolites included carbohydrates, proteins, lipids, and amino acids, and screening for secondary metabolites included phenols, tannins, flavonoids, alkaloids, glycosides, steroids, saponins, terpenes, and resins.

2.6 Total phenolic content (TPC)

The TPC of sample extract was determined using the Folin-Ciocalteu reagent (FCR) method [14]. 1mL sample extract (1 mg.L-1) was vigorously mixed with an equal volume of diluted FCR. After 5 min, 0.75 mL of 1% sodium carbonate solution was added to the mixture and incubated at ambient temperature for 2 h. The absorbance was recorded at 760 nm. The same procedure was adopted for different aliquots of gallic acid. The results were expressed as milligram gallic acid equivalent per gram of dry extract (mg.GAEq.g-1 DE).

2.7 Total flavonoid content (TFC)

The TFC of sample extract was determined using the aluminum chloride (AlCl3) method [15]. 1 mL sample extract was mixed with an equal volume of 2% AlCl3. The mixture was incubated at ambient temperature for 10 min and absorbance was recorded at 415 nm. The same procedure was adopted for the different aliquots of quercetin. The results were expressed as mg. QuEq.g-1 DE.

2.8 Antioxidant activity

The antioxidant activity of each sample extract of T. neotaliala was determined using radical-scavenging activity and reducing power. The results were expressed as milligram Trolox equivalent per gram of dry extract (mg. TEq.g-1 DE).

2.8.1 Radical scavenging activity

The radical scavenging potential was determined by DPPH and ABTS methods.

2.8.1.1 DPPH scavenging activity. The 50 μL of each sample extract was added to a 96 well plate followed by the addition of 150 μL 400 mM DPPH solution [14]. The mixture was kept in dark at ambient temperature for 30 min. The absorbance was recorded at 517 nm. A similar procedure was used for the different aliquot solutions of Trolox. The results were expressed as milligram Trolox equivalent per gram of dried extract (mg.TEq.g-1 DE).

2.8.1.2 ABTS scavenging activity. The ABTS scavenging potential of the sample extract was determined by the formation of the ABTS (2, 2-azino-bis (3-ethylbenzothiazoline) 6-sulfonic acid) + radical cation [14] when a mixture of 7 mM ABTS and 2.45 mM potassium persulfate was kept in the dark at ambient temperature. ABTS+ solution was diluted with methanol until the absorbance value was recoded 0.700 at 734 nm. The 1mL of sample extract solution was mixed with 2 mL ABTS+ solution and incubated for 30 min followed by absorbance measurement at 734 nm. The results were expressed as milligram Trolox equivalent per gram of dried extract (mg. TEq.g-1 DE).

2.8.2 Reducing power assays

The reducing power of sample extract was evaluated by two different methods.

2.8.2.1 CUPRAC. The CUPRAC reducing activity was determined using a previously reported method with some modifications [15]. The 3 mL reaction mixture [10 mM CuCl2, 7.5 mM neocuprion, and 1 M ammonium acetate buffer (pH 7), 1:1:1] was mixed with 0.5mL sample solution (1 mg.mL-1) and incubated at room temperature for 30 min. The absorbance of the resulting solution was recorded at 450 nm. The results were expressed as milligram Trolox equivalent per gram of dry extract (mg. TEq.g-1 DE).

2.8.2.2 FRAP. The FRAP reducing activity was determined using a previously described method [16] with minor modifications. 2 mL reaction mixture [0.3 M acetate buffer (pH 3.6), 20 mM FeCl3, and 10 mM TPTZ solution in 40 mM HCl, 10:1:1] was mixed with 0.1 mL extract solution (1 mg.mL-1). The resulting mixture was incubated at room temperature for 30 minutes. The absorbance was recorded at 593 nm. The results were expressed as milligram Trolox equivalent per gram of dry extract (mg. TEq.g-1 DE).

2.9 Determination of total tannin content (TTC)

The total tannin content sample extract was determined using the Folin-Denis spectrophotometric method [17]. The 1g of sample extract was vigorously mixed with 10 mL distilled water and kept at room temperature for 30 min with occasional stirring. The mixture was centrifuged, and the supernatant was collected. Then, 2.5 mL supernatant and 1 mL Folin-Denis’s reagent were added in a 50mL volumetric flask followed by the addition of 2.5mL Na2CO3 saturated solution. The volume was made up to 50 mL and incubated at room temperature for 90 min. The absorbance was recorded at 250 nm using an IRMECO UV-Vis spectrophotometer (model U2020). The results were expressed as milligram tannic acid equivalent per gram of the dry extract (mg. TAEq.g-1 DE).

2.10 In vitro enzyme inhibition potential

The in vitro biological activity of sample extract was evaluated against two clinically important enzymes. i.e., α-glucosidase and urease.

2.10.1 α-glucosidase inhibition assay

The α-glucosidase inhibition assay was performed according to a previously described method [17] with some modifications. The 10 μL enzyme solution (1U.mL-1) and 50 μL of 50 mM phosphate buffer (pH 6.8) were added to the 96-well plate. 20 μL of the sample extract solution was added to the above mixture and incubated at ambient temperature for 15 min. The absorbance was recorded at 405 nm (pre-read). After that, 20 μL of 0.5 mM para-nitro-α-d-glucopyranoside (substrate) solution was added to the reaction mixture and again incubated at 37°C for 30 min. The absorbance was recorded at 405 nm (after read), and the inhibition (%) was calculated using the following formula

α-glucosidaseinhibition%=1abs.ofsampleabs.ofcontrolx100 (1)

2.10.2 Anti-urease activity

The anti-urease activity of sample extract was determined using a previously reported method with some modifications [18]. The 20 μL of 0.025% urease in 1M phosphate buffer (pH 7.0) and 20 μL of sample solution was added to the same well of 96 microtiter plate and incubated at 37°C for 15 min. Then, 60 μL of 2.25% urea solution was added to the above mixture and incubated again at 37°C for 15 min. The absorbance was measured at 630 nm (pre-read). The 60 μL phenol reagent and 100 μL sodium hypochlorite solution (prepared in alkali) were added to the reaction mixture. The absorbance was recorded at 630 nm. The enzyme inhibition (%) was calculated using the following formula:

Ureaseinhibition%=1abs.ofsampleabs.ofcontrolx100 (2)

2.11 Phytochemical analysis of T. neotaliala by LC-ESI-ITMS2

The insight of bioactive metabolites of BUAE was performed by using tandem mass spectrometry using an LTQ XL linear ion trap mass spectrophotometer (Thermo Scientific, USA) with an electron spray ionization (ESI) interface. The sample was prepared by dissolving the butanol fraction in methanol (MS grade). The Xcalibur data acquisition and interpretation software was used to operate the system. The system was equipped with a column (250 × 2.0 mm ODS-VP C18, 5 μm). Liquid chromatographic conditions included a mobile phase solvent A (0.1% formic acid) and solvent B (methanol). Gradient mode of elution was selected, starting with 5% B (0–5 min), 5–45% B (5–90 min), 45% B (90–100 min), 45–5% B (100–101 min).

The sample was filtered and injected using a direct syringe pump at a flow rate of 5 μL.min-1. The scanning was performed in the positive and negative total ion full-scan modes in the mass scan range of m/z 50–2000. 4.8 kV source voltage and a 23 V capillary voltage were used during the process. Sheath glass flow (N2) was 30 arbitrary units, and the capillary temperature was kept at 350°C in positive and negative scan modes. For the analysis, fragmentation of the eluted compound was performed in both positive (Fig 1) and negative (Fig 2) ion mode using collision-induced dissociation energy of 35% (% of 5 V) [19, 20].

Fig 1. TIC of BUAE in positive ion scan mode.

Fig 1

Fig 2. TIC of BUAE in negative ion scan mode.

Fig 2

2.12 Statistical analysis

The statistical analysis was performed using IBM SPSS Statistics version 20. Each experiment was performed in triplicates and the result was expressed as a mean of triplicate values ± standard deviation (SD). The one-way analysis of variance (ANOVA) was applied to determine the significant difference between the results. The comparison among mean values was made using the least significant difference (LSD) to test for significant differences at P < 0.05.

3 Results

3.1 Phytochemical analysis

The phytochemical analysis of sample extracts revealed the presence of primary and secondary bioactive secondary metabolites (Table 1).

Table 1. Phytochemical screening of T. neotaliala.

Phytochemical Constituent Name of Test HAAE HEAE CFAE BUAE
Carbohydrates Molisch’s test +++ +++ +++ +++
Starch Iodine test +++ +++ +++ +++
Proteins Biuret +++ +++ +++ +++
Amino acids Ninhydrin +++ +++ +++ +++
Phenols Lead acetate +++ +++ +++ ++++
Alkaloids Dragendorff’s test -
Wagner test
Mayer’s test
Erdmann’s test
Flavonoids Amyl alcohol +++ +++ - ++++
Saponins Frothing
Steroids and Terpenes Salkowski’s test ++++ ++++
Glycosides Grignard reaction -
Borntrager’s test -
Tannins Ferric chloride ++++ ++++ ++++ ++++
Resins Acetic acid test

(-) means absent, (+) means present

3.2 Estimation of total phenolic content (TPC)

3.2.1 Total phenolic content (TPC)

The TPC values were determined and presented in Table 2. The results were found between 6.85 ± 0.22 to 234.79 ± 0.12 mg. GA.Eq.g-1 DE. The BUAE showed the highest TPC (234.79 ± 0.12 mg. GA.Eq.g-1 DE) and CFAE showed the lowest TPC (6.85 ± 0.22 mg. GA.Eq.g-1 DE). Statistically, it was revealed that each solvent used had a different capability to extract different phytoconstituents (p < 0.05).

Table 2.
TPC, TFC, and TTC of sample extracts of T. neotaliala* GA.Eq. stands for gallic acid equivalent; Qu.Eq. stands for quercetin equivalent; TA.Eq. stands for tannic acid equivalent; DE stands for dry extract. The expressed values were mean of triplicates ± SD. The mean values in the same column with different letters are significantly different (P < 0.05).

3.3 Estimation of total flavonoid content (TFC)

The BUAE showed highest TFC 320.75 ± 12.50 mg. Qu.Eq.g-1 DE) which was followed by HAAE 224. 92 ± 9.46 mg. Qu.Eq.g-1 DE, HEAE 151.58 ± 10.10 mg. Qu.Eq.g-1 DE, and CFAE 124.08 ± 6.29 mg. Qu.Eq.g-1 DE (Table 2).

3.4 Estimation of total tannin content (TTC)

Similarly, The BUAE showed highest TTC 143.36± 4.32 mg. TA.Eq.g-1 DE followed by CFAE 104.32 ± 4.22 mg.TA.Eq.g-1 DE, HAAE 34.31b ± 1.42 mg. TA.Eq.g-1 DE, and HEAE 17.54 ± 2.54 mg. TA.Eq.g-1 DE.

3.5 Antioxidant activity

The antioxidant results revealed that BUAE > HAAE > HEAE > CFAE as determined by all four antioxidant assays. The results were statistically analyzed which revealed that the antioxidant content of each fraction is significantly (p-value < 0.05) different from others when determined by a single method. A significant relationship was found between the total phenolic content and the antioxidant activity concluding.

3.6 α -glucosidase and anti-urease inhibition assay

The α-glucosidase and urease inhibitory potential of sample extract was determined and their IC50 values were also calculated (Table 3).

Table 3. α-glucosidase and urease inhibition assays of four solvent extracts of T. neotaliala.

Extract/Fractions α-glucosidase Urease
IC50 (mg.mL-1) ± SD IC50 (mg.mL-1) ± SD
HAAE 0.73c ± 0.12 2.18b ± 0.16
HEAE 0.55b ± 0.03 3.54c ± 0.12
CFAE - -
BUAE 0.21a ± 0.09 1.79a ± 0.14
Quercetin 0.01 ± 0.11 -
Hydroxyurea - 0.98 ± 0.12

The values expressed were mean of triplicates ± standard deviation; superscripts a, b, and c, represent the values with significant difference (p < 0.05).

The BUAE exhibited higher α-glucosidase inhibition activity with IC50 value 0.21± 0 mg.mL-1 followed by HEAE IC50 0.56 ± 0.03 mg.mL-1 and HAAE IC50 0.73 ± 0.12 mg.mL-1. The HAAE showed lowest IC50 1.79 ± 0.14 mg.mL-1 as compared to the BUAE IC50 2.18 ± 0.16 mg.mL-1 and HEAE IC50 3.54 ± 0.12 mg.mL-1.

3.7 LC-ESI-MS2 analysis of T. neotaliala

The phytochemical insight of secondary metabolites of BUAE by LCMS revealed the presence of 18 different biologically active phytochemicals (Table 4).

Table 4. The tentative identification of compounds by LCMS analysis of BUAE.

No. RT Compound class Formula MW [M-H]- [M+H]+ Fragmentation pattern Tentatively Identified compound
1 2.93 Di carboxylic acid C12H22O4 146.16 - 147.1 41,55,73,87,100,128 Adipic
acid, hexane
di-oic-acid [21]
2 17.76 Phenolic acid C7H6O5 170.12 169.50 - 125, 169 Gallic acid [22]
3 17.94 Gallate ester C8H8O5 184.15 183.50 - 124,168 Methyl gallate [23, 24]
(Hydrolysable tannin)
4 18.21 Poly cyclic C7H12O6 192.17 191.50 - 173,149,111,93 Quinic acid
[2426]
5 18.21 Carboxylic C6H8O7 192.12 191.50 - 173,111 Citric acid [22, 24, 26]
acid
6 18.21 Phenolic C10H8O4 192 191.50 - 176,191,148,120 Scopoletin [27]
Coumarin
7 19.27 Flavonol C15H9O7 302.235 301.50 - 301,178, 179,173,151,107,93 Quercetin [28, 29]
8 19.27 Phenolic C14H6O8 302 301 - 301,257,229,185 Ellagic acid [25, 30]
acid
9 19.58 Gallotannin (hydrolyzable tannin) C13H16O10 332.26 331.50 - 169,125,271,331 Galloyl
hexoside [24]
10 20.15 Hydrolysable tannin C21H10O13 470.28 469.50 - 425,301,271 Valoneic-di
lactone [30, 31]
11 20.68 Hydrolysable tannin C20H20H14 484 483.50 - 331,211,271,169 Di-O-galloyl
glucose [24]
12 21.52 Hydrolysable tannin C27H22O18 634 633.50 - 275,301,481, Galloyl
HHDP
hexoside [24]
13 21.52 Ellagitannin (Hydrolysable tannin) C27H22O18 634 633 463,301 Corilagin
(1-O-galloyl-
3,6-O-HHDP-
β-ᴅ-Glc) [24]
14 22.52 Phenyl C36H36O13 676 675.50 - 588,513,675 Feruloyl-O-p
propanoid coumaroyl-O
(Hydroxy caffeoyl
cinnamate) shikimic acid [26]
15 22.75 Hydrolysable tannin C34H26O22 786.56 785.5 - 633,419,301,275 Tellimagrandin,
PedunculaginII, (Digalloyl
HHDP-hex) [22, 32]
16 23.12 Hydrolysable tannin C34H26O23 802 801 - 649,301,275 Digalloyl-HHDP-glucuronide [33]
17 23.44 Hydrolysable tannin C41H28O26 936.64 935.50 - 917,783,633,571, 481,419,329,301 Galloyl-bis
HHDP
hexoside
[33]
18 23.44 Ellagitannin (Hydrolysable tannin) C41H28O26 936.64 935.50 - 633,615,659,571, Casuarinin [31, 32]
481

4 Discussion

Owing to the healing power and antioxidant potential, T. chebula was known as the “king of medicine” in Tibet which has been a preferred choice in Ayurvedic Materia Medica [11]. The antioxidant activity of T. arjuna bark was determined by DPPH, superoxide radical quenching, and lipid peroxidation assays and the results revealed that the antioxidant activity was equal to the antioxidant activity of ascorbic acid [26].

The BUAE was screened for its biologically active secondary metabolites by using liquid chromatography-mass spectrometry (LCMS) and identifying eighteen different phytoconstituents. And most of these identified compounds belonged to the subclass of polyphenols known as hydrolyzable tannins which included galloyl hexoside (Fig 3), valoneic-di-lactone (Fig 4), galloyl-HHDP-hexoside (Fig 5), tellimagrandin or Pedunculagin II (Digalloyl-HHDP-hex) (Fig 6), galloyl-bis-HHDP-hexoside (Fig 7), Di-O-galloyl-glucose (Fig 8), digalloyl-HHDP-glucuronide (Fig 9), galloyl tannin, casuarinin (Fig 10), corilagin (Fig 11). The flavanol included quercetin (Fig 12), phenolic acids included gallic acid (Fig 13) and ellagic acid (Fig 14), one methyl ester of gallic acid included methyl gallate (Fig 15), one carboxylic acid included citric acid (Fig 16), one dicarboxylic acid included adipic acid, hexane-di-oic-acid (Fig 17), one phenylpropanoid or hydroxy cinnamate included feruloyl-O-p-coumaroyl-O-caffeoyl shikimic acid (Fig 18), one cyclic polyol included quinic acid (Fig 19), and one coumarin included scopoletin (Fig 20).

Fig 3. The mass spectrum of galloyl hexoside and its fragmentation pattern.

Fig 3

Fig 4. The mass spectrum of valoneic- dilactone and its fragmentation pattern.

Fig 4

Fig 5. The mass spectrum of galloyl HHDP hexoside and its fragmentation pattern.

Fig 5

Fig 6. The mass spectrum of tellimagrandin, pedunculaginII, (Digalloyl HHDP-hex) and its fragmentation pattern.

Fig 6

Fig 7. The mass spectrum of galloyl-bis HHDP hexoside and its fragmentation pattern.

Fig 7

Fig 8. The mass spectrum of di-O-galloyl glucose and its fragmentation pattern.

Fig 8

Fig 9. The mass spectrum of digalloyl-HHDP-glucuronide and its fragmentation pattern.

Fig 9

Fig 10. The mass spectrum of casuarinin and its fragmentation pattern.

Fig 10

Fig 11. The mass spectrum of corilagin (1-O-galloyl- 3,6-O-HHDP- β-ᴅ-Glc) and its fragmentation pattern.

Fig 11

Fig 12. The mass spectrum of quercetin and its fragmentation pattern.

Fig 12

Fig 13. The mass spectrum of gallic acid and its fragmentation pattern.

Fig 13

Fig 14. The mass spectrum of ellagic acid and its fragmentation pattern.

Fig 14

Fig 15. The mass spectrum of methyl gallate and its fragmentation pattern.

Fig 15

Fig 16. The mass spectrum of citric acid and its fragmentation pattern.

Fig 16

Fig 17. The mass spectrum of adipic acid and its fragmentation pattern.

Fig 17

Fig 18. The mass spectrum of feruloyl-O-p coumaroyl-O caffeoyl shikimic acid and its fragmentation pattern.

Fig 18

Fig 19. The mass spectrum of quinic acid and its fragmentation pattern.

Fig 19

Fig 20. The mass spectrum of scopoletin and its fragmentation pattern.

Fig 20

The BUAE showed a significant amount of TPC (234.79 ± 0.12 mg. GA.Eq.g-1 DE) and TFC (320.75 ± 12.50 mg. Qu.Eq.g-1 DE) and TTC which concluded that T. neotaliala was a rich source of polyphenols as previously reported for other species of the genus Terminalia [25, 33]. Similarly, BUAE also showed strong antioxidant activity followed by HAAE, HEAE, and CFAE determined by all the described methods (Fig 21). Terminalia showed antioxidant potential owing to a wide variety of polyphenols and flavonoids [34, 35]. Polyphenol structures are ideal for free radical scavenging potential [36]. Tannins were abundant antioxidants in the human diet nevertheless they were often a neglected class of polyphenols. The TTC determination revealed that the highest level of tannins was present in the butanol fraction of the aerial parts of T. neotaliala (143.32 ± 4.32 mg. TA.Eq.g-1 DE). The literature survey confirmed the presence of hydrolyzable and condensed tannins in genus Terminalia those who were reported with a high amount of TPC and TFC. The statistical analysis of TPC, TFC, TTC, and antioxidant activity revealed that each sample extract solution i.e., HAAE, HEAE, CFAE, and BUAE; was significantly different from the other sample extract solution (p < 0.05). The tannins can function as chain-terminating antioxidants, metal chelators, reducing agents, scavengers of reactive oxygen species, and quenchers of singlet oxygen. The chloroform showed poor affinity to extract hydrolyzable tannins during extraction; therefore, CFAE exhibited the lowest polyphenolic content 6.86 ± 0.22 mg.GAE.g-1 DE. The tannins, especially hydrolyzable tannins (HTs), constitute a major class of plant secondary metabolites, including simple gallic acid derivatives, gallotannins, and ellagitannins [37]. Tannins, especially hydrolyzable tannins, have attracted attention in recent decades because of their antioxidant potential and biological activity [38]. Many ellagitannins and hydrolyzable tannins, including ellagic acid, gallic acid, methyl gallate, ethyl gallate, chebulinic acid, corilagin, penta galloyl glucose, tetra galloyl beta-D-glucose, and casuarinin from the dichloromethane fraction of T. chebula fruit, improved type II collagen-induced arthritis in BALB/c mice [39]. These tannins were involved in the wound healing process by increasing the rate of epithelization [40].

Fig 21. Antioxidant activity of four sample extracts of T. neotaliala determined by DPPH, ABTS, CUPRAC, and FRAP assays.

Fig 21

The antioxidant results were statistically analyzed by one-way ANOVA using SPSS software, that the antioxidant content of each sample extract was significantly different from the antioxidant content of others (p-value < 0.05) which indicated that each solvent had a different capacity to extract phytoconstituents depending on its polarity and chemical structure.

Type II diabetes is one of the most prevalent metabolic disorders both in low and high-income countries being managed by improving insulin secretion and controlling blood glucose levels by administering oral hypoglycemic drugs such as α-glucosidase inhibitors, sulfonylureas, and biguanides. The inhibition of α-glucosidase found in the epithelium of the small intestine delays the postprandial hyperglycemia by blocking the conversion of disaccharides into monosaccharides. There are only two marketed available α-glucosidase inhibitors i.e., acarbose and miglitol and therefore, there is an open field for the discovery of NMEs exploiting the natural resources. The BUAE significantly inhibited α-glucosidase with the lowest IC50 value 0.21 ± 0.09 mg.mL-1, followed by HEAE and HAAE. It was found through literature that the antidiabetic effects of the sample extract were owing to the ability of hydrolyzable tannins to block glucose intestinal epithelial uptake, glycogen, and lipid synthesis [41].

The urease is a virulence factor in human and animal pathogens that can cause kidney stones, pyelonephritis, peptic ulcers, urolithiasis, hepatic encephalopathy, and hepatic coma [42]. The urease inhibitor prevents microorganisms from catalyzing urea into ammonia and carbon dioxide creating unfavorable conditions for their survival by restricting their major source of energy and nitrogen. This anti urease potential creates a good antimicrobial therapeutic option. The urease inhibitors have recently attracted attention owing to their anti-ulcerative potential [43]. Moreover, the recent increase in microbial antibiotic resistance and poor patient compliance necessitates the discovery of new inhibitors with better effectiveness and simpler regimens[44]. The anti-urease inhibitory potential was observed as BUAE > HAAE > HEAE> CFAE. The urease inhibitory activity of the BUAE may be attributed to the presence of hydrolyzable tannins and phenolic acids. The anti-urease activity of hydrolyzable tannin was due to the hydrogen bonding and hydrophobic interactions with the active site of urease [45]. A well-known flavanol i.e., quercetin, showed significant antioxidant, anticancer, anti-inflammatory, and antiviral activities. It has been considered therapeutically for its gastro-protective effects, inhibition of carcinogenicity, and reduction in the risk of cataracts. The allergic and anti-inflammatory response of quercetin was mediated by suppressing leukotriene production [46]. The corilagin inhibited glucose-6-phosphatase, fructose 1,6-bisphosphatase, and α-glucosidase [47]. These natural antioxidants may be promising drug candidates against various allergic and inflammatory conditions, metabolic disorders, and cancers. The quinic acid showed anticarcinogenic properties by up-regulating the cellular antioxidant enzymes and protecting them against the TPA-induced carcinogenesis [48]. The scopoletin a phenolic coumarin, inhibited the growth of breast and colon cancer cell lines [49, 50].

The high antioxidant activity of high molecular weight tannins was attributed to the number of phenolic–OH groups. The literature review revealed that casuarinin a hydrolyzable tannin isolated from T. arjuna was effective against lung cancer [51].

5 Conclusion

The present study concluded that BUAE secured from methanol extract of aerial parts of Terminalia neotaliala showed significant antioxidant activity determined by the DPPH, ABTS, FRAP, and CUPRAC assay. The BUAE also confirmed the highest TTC, TPC, and TFC which were responsible for pharmacological activities validating its ethnobotanical and medicinal importance. LCMS metabolomic profiling of BUAE confirmed the presence of many hydrolyzable tannins in addition to other biologically active phytoconstituents. The strong antioxidant and enzyme inhibitory activity also concluded that the aerial part of T. neotaliala can be a promising source of new drug molecules for the treatment and mitigation of different inflammatory conditions, metabolic disorders, and cancer. The BUAE can be further exploited for the discovery of novel pharmaceutical products through different isolation techniques i.e., normal, and reversed-phase column chromatography, preparative TLC, and preparative HPLC.

Data Availability

All relevant data are within the manuscript.

Funding Statement

The authors received no funding for this work.

References

  • 1.Che C.-T., et al., Traditional medicine, in Pharmacognosy. 2017, Elsevier. p. 15–30. [Google Scholar]
  • 2.Pandhair V. and Sekhon B., Reactive oxygen species and antioxidants in plants: an overview. Journal of plant Biochemistry and Biotechnology, 2006. 15(2): p. 71–78. [Google Scholar]
  • 3.Martinez-Cayuela M., Oxygen free radicals and human disease. Biochimie, 1995. 77(3): p. 147–161. doi: 10.1016/0300-9084(96)88119-3 [DOI] [PubMed] [Google Scholar]
  • 4.Young I. and Woodside J., Antioxidants in health and disease. Journal of clinical pathology, 2001. 54(3): p. 176–186. doi: 10.1136/jcp.54.3.176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nimse S.B. and Pal D., Free radicals, natural antioxidants, and their reaction mechanisms. RSC advances, 2015. 5(35): p. 27986–28006. [Google Scholar]
  • 6.Halliwell B. and Gutteridge J.M., [1] Role of free radicals and catalytic metal ions in human disease: an overview. Methods in enzymology, 1990. 186: p. 1–85. doi: 10.1016/0076-6879(90)86093-b [DOI] [PubMed] [Google Scholar]
  • 7.Middleton E., Kandaswami C., and Theoharides T.C., The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacological reviews, 2000. 52(4): p. 673–751. [PubMed] [Google Scholar]
  • 8.Oboh G. and Rocha J., Distribution and antioxidant activity of polyphenols in ripe and unripe tree pepper (Capsicum pubescens). Journal of Food Biochemistry, 2007. 31(4): p. 456–473. [Google Scholar]
  • 9.Uyoh E.A., et al., Evaluation of antioxidant capacity of two Ocimum species consumed locally as spices in Nigeria as a justification for increased domestication. 2013. doi: 10.3109/09637486.2012.704903 [DOI] [PubMed] [Google Scholar]
  • 10.Fahmy N., Al-Sayed E., and Singab A., Genus Terminalia: A phytochemical and biological review. Montin.) species. Med Aromat Plants, 2015. 4(5): p. 1–22. [Google Scholar]
  • 11.Bognan A.J.A.A., et al., Antifungal Activity of Terminalia mantaly on the in vitro Growth of Cryptococcus neoformans. 2013. [Google Scholar]
  • 12.Toghueo R., et al., Enzymatic activity of endophytic fungi from the medicinal plants Terminalia catappa, Terminalia mantaly and Cananga odorata. South African Journal of Botany, 2017. 109: p. 146–153. [Google Scholar]
  • 13.Grochowski D.M., et al., In vitro antioxidant and enzyme inhibitory properties of Rubus caesius L. International journal of environmental health research, 2019. 29(3): p. 237–245. doi: 10.1080/09603123.2018.1533532 [DOI] [PubMed] [Google Scholar]
  • 14.Świątek Ł., et al., LC-ESI-QTOF-MS/MS Analysis, Cytotoxic, Antiviral, Antioxidant, and Enzyme Inhibitory Properties of Four Extracts of Geranium pyrenaicum Burm. f.: A Good Gift from the Natural Treasure. International journal of molecular sciences, 2021. 22(14): p. 7621. doi: 10.3390/ijms22147621 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zengin G., et al., Screening of in vitro antioxidant and enzyme inhibitory activities of different extracts from two uninvestigated wild plants: Centranthus longiflorus subsp. longiflorus and Cerinthe minor subsp. auriculata. European Journal of Integrative Medicine, 2016. 8(3): p. 286–292. [Google Scholar]
  • 16.Ezebo R., et al., Phytochemical Screening and Antimicrobial Activity of Ethanol and Methanol Extracts of Lantana camara Leaf. World News of Natural Sciences, 2021. 37: p. 151–163. [Google Scholar]
  • 17.Qaisar M.N., et al., Evaluation of α-glucosidase inhibitory activity of dichloromethane and methanol extracts of Croton bonplandianum Baill. Tropical Journal of Pharmaceutical Research, 2014. 13(11): p. 1833–1836. [Google Scholar]
  • 18.Khan K.M., et al., Synthesis and in vitro urease inhibitory activity of N, N′-disubstituted thioureas. European journal of medicinal chemistry, 2014. 74: p. 314–323. doi: 10.1016/j.ejmech.2014.01.001 [DOI] [PubMed] [Google Scholar]
  • 19.Yasmin S., et al., Biocontrol of bacterial leaf blight of rice and profiling of secondary metabolites produced by rhizospheric Pseudomonas aeruginosa BRp3. Frontiers in Microbiology, 2017. 8: p. 1895. doi: 10.3389/fmicb.2017.01895 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Akbar N., et al., Gut bacteria of Cuora amboinensis (turtle) produce broad-spectrum antibacterial molecules. Scientific reports, 2019. 9(1): p. 1–19. doi: 10.1038/s41598-018-37186-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.El-sayed M., et al., UPLC-ESI-MS/MS Profile of The Ethyl Acetate Fraction of Aerial Parts of Bougainvillea’Scarlett O’Hara’Cultivated in Egypt. Egyptian Journal of Chemistry, 2021. 64(2): p. 793–806. [Google Scholar]
  • 22.Abu-Reidah I.M., et al., HPLC–DAD–ESI-MS/MS screening of bioactive components from Rhus coriaria L.(Sumac) fruits. Food chemistry, 2015. 166: p. 179–191. doi: 10.1016/j.foodchem.2014.06.011 [DOI] [PubMed] [Google Scholar]
  • 23.Mekam P.N., et al., Phenolic compounds profile of water and ethanol extracts of Euphorbia hirta L. leaves showing antioxidant and antifungal properties. South African Journal of Botany, 2019. 127: p. 319–332. [Google Scholar]
  • 24.Kramberger K., et al., HPLC-DAD-ESI-QTOF-MS determination of bioactive compounds and antioxidant activity comparison of the hydroalcoholic and water extracts from two Helichrysum italicum species. Metabolites, 2020. 10(10): p. 403. doi: 10.3390/metabo10100403 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Liu Y. and Seeram N.P., Liquid chromatography coupled with time-of-flight tandem mass spectrometry for comprehensive phenolic characterization of pomegranate fruit and flower extracts used as ingredients in botanical dietary supplements. Journal of separation science, 2018. 41(15): p. 3022–3033. doi: 10.1002/jssc.201800480 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Yisimayili Z., et al., A comprehensive study of pomegranate flowers polyphenols and metabolites in rat biological samples by high-performance liquid chromatography quadrupole time-of-flight mass spectrometry. Journal of Chromatography A, 2019. 1604: p. 460472. doi: 10.1016/j.chroma.2019.460472 [DOI] [PubMed] [Google Scholar]
  • 27.Fischer U.A., Carle R., and Kammerer D.R., Identification and quantification of phenolic compounds from pomegranate (Punica granatum L.) peel, mesocarp, aril and differently produced juices by HPLC-DAD–ESI/MSn. Food chemistry, 2011. 127(2): p. 807–821. doi: 10.1016/j.foodchem.2010.12.156 [DOI] [PubMed] [Google Scholar]
  • 28.Fathoni, A., et al. Identification of nonvolatile compounds in clove (Syzygium aromaticum) from Manado. in AIP Conference Proceedings. 2017. AIP Publishing LLC.
  • 29.Aldes L., Fitriliana F., and Risfidian M., Conversion of cyclohexanone to adipic acid catalyzed by heteropoly compounds. Indones. J. Chem., 2015. 15(1): p. 64–69. [Google Scholar]
  • 30.Mena P., et al., Rapid and comprehensive evaluation of (poly) phenolic compounds in pomegranate (Punica granatum L.) juice by UHPLC-MSn. Molecules, 2012. 17(12): p. 14821–14840. doi: 10.3390/molecules171214821 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Wyrepkowski C.C., et al., Characterization and quantification of the compounds of the ethanolic extract from Caesalpinia ferrea stem bark and evaluation of their mutagenic activity. Molecules, 2014. 19(10): p. 16039–16057. doi: 10.3390/molecules191016039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ben Said R., et al., Tentative characterization of polyphenolic compounds in the male flowers of Phoenix dactylifera by liquid chromatography coupled with mass spectrometry and DFT. International journal of molecular sciences, 2017. 18(3): p. 512. doi: 10.3390/ijms18030512 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Barry K., Davies N., and Mohammed C., Identification of hydrolysable tannins in the reaction zone of Eucalyptus nitens wood by high performance liquid chromatography–electrospray ionisation mass spectrometry. Phytochemical Analysis: An International Journal of Plant Chemical and Biochemical Techniques, 2001. 12(2): p. 120–127. doi: 10.1002/pca.548 [DOI] [PubMed] [Google Scholar]
  • 34.Çelik S.E., et al., Antioxidant capacities of herbal plants used in the manufacture of van herby cheese:‘Otlu Peynir’. International Journal of Food Properties, 2008. 11(4): p. 747–761. [Google Scholar]
  • 35.Baratelli T.d.G., et al., Phytochemical and allelopathic studies of Terminalia catappa L.(Combretaceae). Biochemical Systematics and Ecology, 2012. 41: p. 119–125. [Google Scholar]
  • 36.Zengin G. and Aktumsek A., Investigation of antioxidant potentials of solvent extracts from different anatomical parts of Asphodeline anatolica E. Tuzlaci: An endemic plant to Turkey. African Journal of Traditional, Complementary and Alternative Medicines, 2014. 11(2): p. 481–488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Amadi S.W., Zhang Y., and Wu G., Research progress in phytochemistry and biology of Aframomum species. Pharmaceutical Biology, 2016. 54(11): p. 2761–2770. doi: 10.3109/13880209.2016.1173068 [DOI] [PubMed] [Google Scholar]
  • 38.Li Y., et al., Comparison analysis of widely-targeted metabolomics revealed the variation of potential astringent ingredients and their dynamic accumulation in the seed coats of both Carya cathayensis and Carya illinoinensis. Food Chemistry, 2022. 374: p. 131688. doi: 10.1016/j.foodchem.2021.131688 [DOI] [PubMed] [Google Scholar]
  • 39.Ekambaram S.P., et al., Hydrolysable tannin-rich fraction from Terminalia chebula Retz. fruits ameliorates collagen-induced arthritis in BALB/c mice. Inflammopharmacology, 2020. 28(1): p. 275–287. doi: 10.1007/s10787-019-00629-x [DOI] [PubMed] [Google Scholar]
  • 40.Kaneshima T., et al., Antimicrobial constituents of peel and seeds of camu-camu (Myrciaria dubia). Bioscience, Biotechnology, and biochemistry, 2017. 81(8): p. 1461–1465. doi: 10.1080/09168451.2017.1320517 [DOI] [PubMed] [Google Scholar]
  • 41.Smeriglio A., et al., Proanthocyanidins and hydrolysable tannins: occurrence, dietary intake and pharmacological effects. British journal of pharmacology, 2017. 174(11): p. 1244–1262. doi: 10.1111/bph.13630 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Uddin G., et al., Urease inhibitory profile of extracts and chemical constituents of Pistacia atlantica ssp. cabulica Stocks. Natural Product Research, 2016. 30(12): p. 1411–1416. doi: 10.1080/14786419.2015.1062378 [DOI] [PubMed] [Google Scholar]
  • 43.Amtul Z., Siddiqui R., and Choudhary M., Chemistry and mechanism of urease inhibition. Current medicinal chemistry, 2002. 9(14): p. 1323–1348. doi: 10.2174/0929867023369853 [DOI] [PubMed] [Google Scholar]
  • 44.Nishimori I., et al., Carbonic anhydrase inhibitors: the β-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors. Bioorganic & medicinal chemistry letters, 2007. 17(13): p. 3585–3594. doi: 10.1016/j.bmcl.2007.04.063 [DOI] [PubMed] [Google Scholar]
  • 45.Ali Khan M.S., Nazan S., and Mat Jais A.M., Flavonoids and anti-oxidant activity mediated gastroprotective action of leathery murdah, Terminalia coriacea (roxb.) wight & arn. leaf methanolic extract in rats. Arquivos de gastroenterologia, 2017. 54: p. 183–191. doi: 10.1590/S0004-2803.201700000-21 [DOI] [PubMed] [Google Scholar]
  • 46.Shukla P., Shukla P., and Gopalkrishna B., Isolation and characterization of polyphenolic compound quercitin from Phyllanthus emblica. International journal of pharmaceutical sciences and research, 2012. 3(5): p. 1520. [Google Scholar]
  • 47.Cock I., The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae). Inflammopharmacology, 2015. 23(5): p. 203–229. doi: 10.1007/s10787-015-0246-z [DOI] [PubMed] [Google Scholar]
  • 48.Liu W., et al., Synthesis and in vitro antitumor activity of novel scopoletin derivatives. Bioorganic & medicinal chemistry letters, 2012. 22(15): p. 5008–5012. doi: 10.1016/j.bmcl.2012.06.014 [DOI] [PubMed] [Google Scholar]
  • 49.Napiroon T., et al., Scopoletin from Lasianthus lucidus Blume (Rubiaceae): A potential antimicrobial against multidrug-resistant Pseudomonas aeruginosa. Journal of Applied Pharmaceutical Science, 2018. 8(9): p. 1–6. [Google Scholar]
  • 50.Barbehenn R.V., et al., Ellagitannins have greater oxidative activities than condensed tannins and galloyl glucoses at high pH: potential impact on caterpillars. Journal of chemical ecology, 2006. 32(10): p. 2253–2267. doi: 10.1007/s10886-006-9143-7 [DOI] [PubMed] [Google Scholar]
  • 51.Kuo P.-L., et al., Casuarinin from the bark of Terminalia arjuna induces apoptosis and cell cycle arrest in human breast adenocarcinoma MCF-7 cells. Planta medica, 2005. 71(03): p. 237–243. doi: 10.1055/s-2005-837823 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

A M Abd El-Aty

26 Nov 2021

PONE-D-21-31614Profiling of phytochemicals from aerial parts of Terminalia neotaliala using LC-ESI-MS and determination of antioxidant and enzyme inhibition activitiesPLOS ONE

Dear Dr. Shahzad,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: As appended below, the reviewers have raised major concerns/critiques and suggested further justification/work to consolidate the findings. Do go through the comments and amend the MS accordingly.

==============================

Please submit your revised manuscript by Jan 10 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

A. M. Abd El-Aty

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

3. Please ensure that you refer to Figure 2 to 22 in your text as, if accepted, production will need this reference to link the reader to the figure

4. Please upload a copy of Figures 17 to 22 to which you refer in your text on page 20. If the figure is no longer to be included as part of the submission please remove all reference to it within the text.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have made huge effort to address previously raised issues and improve the quality of their manuscript for re-submission. However, I still have doubt on the structural identification process. As noted before, the authors stated that they identified the polyphenols from butanol extract by comparing with previous literature and using LC-MS/MS. I suggested the authors to explicitly describe the fragmentation pattern of each molecule, and also support their identification process and compound elution order using available standards. However, the authors did not conduct or incorporate any of these in the resubmitted manuscript. They sated that they cannot conduct additional experiment/analysis for unknown reason. Therefore, I still consider that these issues are critical and must be fully addressed for the manuscript to be considered for publication.

Reviewer #2: The manuscript PONE-D-21-31614 was revised for English language and the quality of the presentation and description of the data have been notably improved. The quality of figures 2-22 must be improved and then the work can be accepted and be published in Plos One

Reviewer #3: This study showed the Phytochemical profiling of Terminalia neotaliala by LC-ESI-MS: Antioxidant and enzyme inhibition activity. This paper showed Strong antioxidant activity and presence of high molecular weight hydrolysable tannins by LC-ESI-MS suggest medicinal importance of T. neotaliala. Therefore, I would like to suggest to be accepted this manuscript after the improvement as a whole.

1. Line 54, Total phenolic content (TPC) → total phenolic content (TPC)

2. Line 56, Total tannin content (TTC) → TTC

3. Line 116, 143, 160,….etc. in manusctript, figure , table, Terminalia neotaliala → T. neotaliala. You did not revise at all. You should write full name (Terminalia neotaliala) when you firstly mention the academic name in manuscript, figure, table and then should write as abbreviation (T. neotaliala)

4. Table 4, you should check and revise the subscript in formula.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-21-31614 (2021.11.15).docx

PLoS One. 2022 Mar 31;17(3):e0266094. doi: 10.1371/journal.pone.0266094.r003

Author response to Decision Letter 0


4 Jan 2022

Response to reviewer 1: as per suggestion by the reviewer 1, the manuscript was improved by incorporation of each molecular fragmentation pattern after extensively reviewing the available literature. The quality of each molecular ionogram was also improved. The molecule (132-Hydroxypheophorbide-α-methyl ester) incorporated in table 4, serial # 2 with retention time 5.15 and molecular weight 622 gm/mol belongs to chloroform fraction of T. neotaliala which was mistakenly incorporated in butanol fraction (subjected) LC-ESI-MS2 molecular table, due to this author were questioned about the order of elution like higher molecular weight eluting before the low molecular weight compounds. Now the mistakenly incorporated misfit compound has been removed from the list of identified compounds. Kindly find the ion-gram of mentioned molecular compound which clearly indicates the chloroform fraction in its description with further details. The authors could not go for further analysis because the LC-ESI-MS2 facility was availed from other institute who unfortunately did not have all of the identified standards therefore it’s not feasible for authors to buy each of the standard compounds and run them again due to financial limitations. Therefore, authors have extensively reviewed the previous literature and included the fragmentation patter of each identified compound for supporting the identification process to satisfy the reviewer 1.

Response to Reviewer 2.

The quality of English and scientific language has been improved. Similarly, quality of figures 2-21 have been improved at their best quality for possible publication of our manuscript in Plos One.

response to Reviewer 3.

Thanks for the positive comments of the reviewer. The suggested corrections have been made in the revised manuscript.

Attachment

Submitted filename: response to reviewers .docx

Decision Letter 1

A M Abd El-Aty

17 Jan 2022

PONE-D-21-31614R1Profiling of phytochemicals from aerial parts of Terminalia neotaliala using LC-ESI-MS and determination of antioxidant and enzyme inhibition activitiesPLOS ONE

Dear Dr. Shahzad,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Still reviewer is raising some comments over the revised form of the MS. Do go through the comments and amend the MS, accordingly. Afterwards, proofread the text for grammar and syntax errors, if any.

==============================

Please submit your revised manuscript by Mar 03 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

A. M. Abd El-Aty

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed most of the issues and improved the quality of the manuscript. Once gain, I suggest the authors consider the following minor comments.

-It is preferable to avoid the use of abbreviations while listing keywords.

-Please reflect the statistical analysis data in figure 1 (i.e show if there is any significant variation in each of the antioxidant activities according to extract types).

-Figures are duplicated and hence, need revision.

-The authors have already indicated that the results are reported as mean ± SD (lines 306-307). Thence, it is better to avoid the unnecessary repetition of "SD" while mentioning numerical values in the result and discussion sections (for instance: 234.79 ± 0.12 mg. GAEq.g-1 DE±SD can be rewritten as 234.79 ± 0.12 mg GAEq g-1 DE (line 324), and so forth).

-In the reference section, there is a huge inconsistency in reference listing. Authors are advised to follow the journal's guideline.

-Last but not least, the manuscript still needs a thorough edition and revision towards its language use (preferably by a native speaker).

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Mar 31;17(3):e0266094. doi: 10.1371/journal.pone.0266094.r005

Author response to Decision Letter 1


22 Feb 2022

Reviewer #1: (suggestions)

1. It is preferable to avoid the use of abbreviations while listing keywords.

Response

The suggestion has complied while listing keywords

2. please reflect the statistical analysis data in figure 1 (i.e. show if there is any significant variation in each of the antioxidant activities according to extract types).

Response

A statement has been incorporated after statistical analysis

3. Figures are duplicated and hence, need revision.

Response

Duplicate figures have been removed

4. The authors have already indicated that the results are reported as mean ± SD (lines 306-307). Thence, it is better to avoid the unnecessary repetition of "SD" while mentioning numerical values in the result and discussion sections (for instance: 234.79 ± 0.12 mg. GAEq.g-1 DE±SD can be rewritten as 234.79 ± 0.12 mg GAEq g-1 DE (line 324), and so forth).

Response

The said suggestion has complied throughout the manuscript

5. In the reference section, there is a huge inconsistency in the reference listing. Authors are advised to follow the journal's guidelines.

Response

The suggestion has complied in the bibliography

6. Last but not least, the manuscript still needs a thorough edition and revision towards its language use (preferably by a native speaker).

Response

The manuscript has been completed edited and revised towards its language

Attachment

Submitted filename: respone to reviewer 21.docx

Decision Letter 2

A M Abd El-Aty

28 Feb 2022

PONE-D-21-31614R2Profiling of phytochemicals from aerial parts of Terminalia neotaliala using LC-ESI-MS2 and determination of antioxidant and enzyme inhibition activitiesPLOS ONE

Dear Dr. Shahzad,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: As raised by the reviewer, the MS needs language editing  for grammar and syntax errors. Check also Fig. 1 as stated in the comments.

==============================

Please submit your revised manuscript by Apr 14 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

A. M. Abd El-Aty

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed most of the issues raised during the two rounds of revisions. The manuscript could be accepted for publication provided that an extensive revision and edition is made towards its language. Besides, figure 1 still needs to show statistical analysis results.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Mar 31;17(3):e0266094. doi: 10.1371/journal.pone.0266094.r007

Author response to Decision Letter 2


9 Mar 2022

Reviewer #1: Response to comments

1. The manuscript has been completely revised and edited, toward the English language.

2. The statistical result of figure 1 has been sufficiently described.

Attachment

Submitted filename: response to reviewer 3 nadeem .docx

Decision Letter 3

A M Abd El-Aty

15 Mar 2022

Profiling of phytochemicals from aerial parts of Terminalia neotaliala using LC-ESI-MS2 and determination of antioxidant and enzyme inhibition activities

PONE-D-21-31614R3

Dear Dr. Shahzad,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

A. M. Abd El-Aty

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed the issues raised during the three rounds of revisions. Now, the manuscript can be considered for publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

A M Abd El-Aty

18 Mar 2022

PONE-D-21-31614R3

Profiling of phytochemicals from aerial parts of Terminalia neotaliala using LC-ESI-MS2 and determination of antioxidant and enzyme inhibition activities

Dear Dr. Shahzad:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. A. M. Abd El-Aty

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Rebuttal letter.docx

    Attachment

    Submitted filename: PONE-D-21-31614 (2021.11.15).docx

    Attachment

    Submitted filename: response to reviewers .docx

    Attachment

    Submitted filename: respone to reviewer 21.docx

    Attachment

    Submitted filename: response to reviewer 3 nadeem .docx

    Data Availability Statement

    All relevant data are within the manuscript.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES